ClinicalTrials.gg
DrugCombination product

Zabadinostat clinical trials

Its developmentBy ImmunityBio and Celleron Therapeutics, step by step2 company-led studies, furthest phase 2: when each phase was reached, its deals, target and what is ahead.
studies test it
5
open now
0
in phase 3
0
first study started
2014

How each study uses zabadinostat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

CXD101
1
AZD9468
1

Studies by the year they started

5 studies that test it; most in 2014 (1)

Studies that test zabadinostat, by start year
YearStudies
20141
20181
20191
20231
20261

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 3

Stephen Chan Lam (1) · Oxford University Hospitals NHS Trust (1) · Celleron Therapeutics Ltd. (1) · ImmunityBio, Inc. (1) · University College, London (1)

Often tested with

Tested in the same studies.

Nogapendekin alfa inbakicept (1) · Sotevtamab (1) · Albumin-Bound Paclitaxel (1) · Paclitaxel (1) · Gemcitabine (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses zabadinostat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 5

Codes

What other systems call zabadinostat · ClinicalTrials.gg INT015123

  • UNII (FDA) 5TNV87ICD2ZABADINOSTATConfirmed FDA, Wikidata
  • Wikidata Q119852211zabadinostatConfirmed FDA, Wikidata
  • NCI Thesaurus C112177ZabadinostatOne source FDA
  • DrugBank DB16182One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.